Ensuring Patient Adherence in Paediatric and Geriatric Populations

Patient noncompliance costs US healthcare payers an estimated $330 billion annually, according to a recent study. With value of care increasingly determining a medicine’s market success, many pharmaceutical companies are recognizing the importance of adopting a patient-centric approach to formulation development, especially for products designed for children and the elderly.

In this article published in Pharmaceutical Technology, Dr Martin Koeberle (Head of Analytical Development and Stability Testing at HERMES PHARMA) and other industry experts discuss:

  • The essential factors to consider when designing medicines to meet the needs of children and the elderly
  • How user-friendly dosage forms can be used to enhance patient experience and adherence
  • The importance of taste masking and flavoring when developing user-friendly formulations
  • How controlled-release formulations and fixed-dose combination drugs can improve patient quality of life